tm logo
FOLDIKINE
Live/Registered
REGISTERED

on 26 Mar 2024

Last Applicant/ Owned by

Serial Number

79366890 filed on 07th Dec 2022

Registration Number

7334166 registered on 26th Mar 2024

in the Principal Register

Correspondent Address

Stephanie N. Nikitenko

IpHorgan Ltd

195 Arlington Heights Rd, Suite #125

Buffalo Grove,IL 60089

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

FOLDIKINE

Scientific and technological services, namely, scientific research ; research and development of products; design and development of biological, pharmaceutical and veterinary products; medical, pharmacological and veterinary research services; research related to molecular science; research and development services in immunology; research and development services in the field of immunohistology; r Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific and technological services, namely, scientific research ; research and development of products; design and development of biological, pharmaceutical and veterinary products; medical, pharmacological and veterinary research services; research related to molecular science; research and development services in immunology; research and development services in the field of immunohistology; research and development services with respect to immunomodulatory molecules; laboratory research services in relation to the production of immunomodulatory biological molecules and chimeras thereof; software design and development; information, advisory, and consultancy relating to the aforesaid services

Class [005]
Pharmaceutical Products


Pharmaceutical preparations for the treatment of immune-mediated diseases; veterinary preparations for the treatment of immune-mediated diseases; biological preparations for medical use for the treatment of immune-mediated diseases; biological preparations for veterinary purposes for the treatment of immune-mediated diseases; immunomodulators; immunosuppressants; immunostimulants; growth factors, namely, cell growth media for growing cells for medical or clinical use; cell survival factors, namely cell growth media for growing cells for medical or clinical use; pharmaceutical and veterinary preparations for regulating the immune system; pharmaceutical and veterinary preparations for the treatment and/or prevention of diseases and disorders of the immune system or those affecting the immune system; regulatory proteins for medical and veterinary use in the nature of protein arrays for medical use and medical diagnosis purposes

Class [001]
Chemical Products


Protein in raw material form for scientific and medical research; proteins for use in science; proteins for use in industry; proteins for use in the manufacture of cosmetics; biological preparations for industry and science; biological preparations for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for scientific use, other than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for industrial use, other than for medical or veterinary use; immunomodulatory biological molecules and chimeras thereof for use in the manufacture of cosmetics; immunomodulatory biological molecules and chimeras thereof for use in laboratories, other than for medical or veterinary use; culture media for microbiology for scientific and research use; culture media of eukaryotic cells, in particular, immune, lymphoid and myeloid cells for scientific and research use

Mark Details


Serial Number

No 79366890

Mark Type

No Service Mark

Attorney Docket Number

No CLV 1292 US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
26th Mar 2024REGISTERED-PRINCIPAL REGISTER
26th Mar 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Jan 2024PUBLISHED FOR OPPOSITION
09th Jan 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08th Jan 2024NOTIFICATION PROCESSED BY IB
20th Dec 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20th Dec 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20th Dec 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29th Nov 2023APPROVED FOR PUB - PRINCIPAL REGISTER
14th Nov 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED